Rheumnow Podcast

Rheum + Pulm Collaborations in ILD

Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 4: Rheum + Pulm Collaborations in ILD including The Rheumatologist and Pulmonologist: Different approaches to the same patient (Dr. Paul Dellaripa and Dr Rachel Putman).

ILD Assessment and Management

Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 3: ILD Assessment and Management including: Biomarkers in ILD (Dr. Elena Joerns), How to Assess ILD in Patients (Dr. Janet Pope) and Management of SSc ILD (Dr. Alicia Hinze)

ILD Treatment

Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 2: ILD Treatment including: RA-ILD Treatment Update (Dr. Bryant England), Do DMARDS Affect CTD-ILD Outcomes? (Dr. Elizabeth Volkmann), Non-pharmacologic Treatment of ILD (Dr. Jon Giles) and Transplantation: A real option! (Dr. John Joerns)

ILD Guidelines

Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 1: ILD Guidelines including: ACR/CHEST Guidelines for SSc ILD (Dr. Sindhu Johnson), ERS/EULAR Clinical Practice Guidelines (Dr. Anna-Maria Hoffman-Vold) and ILD Guideline Caveats and Concerns (Dr. Jeffrey Sparks). 

How Does Your Garden Grow (9.26.2025)

Dr. Jack Cush reviews the news and journal articles from RheumNow.com.  Pool therapy, Fibrosis, NSIE's and whats best for knee OA.

QD clinics on ILD - lessons from the Clinic #3

QD clinics on ILD - lessons from the Clinic; brought to during the "Rheum to Breathe" ILD campaign

ILD QD Clinic #3
ILD QD Clinic: Application of the ACR CHEST Guidelines to Two Cases  
ILD QD Clinic: Progressive RA-ILD Management 
ILD QD Clinic: Beyond the Numbers in Newly Diagnosed ILD 

Rheum to Breathe Journal Club

In this journal club, we will discuss two pivotal studies in ILD, the FIBRONEER study and the RECITAL study:

Nerandomilast in Patients with Progressive Pulmonary Fibrosis, Maher, T.M. et al. NEJM. 2025 May 19. doi: 10.1056

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial, Maher T.M., et al. Lancet 2023 Jan;11(1). doi: 10.1016

Panelists:
Toby Maher, MD
Shervin Assassi, MD
Jack Cush, Moderator

DERM on RheumNow Podcast (September 2025)

Content curated for dermatologists and skin deep HCPs – on Psoriasis, CLE, vasculitis, HS and dermatology drugs use, efficacy and side effects and more. 
Features Dr. Jack Cush, Editor at RheumNow.com.
SHOW NOTES:
1. SMILE Study: A randomized, placebo-controlled trial of hydroxychloroquine in incomplete lupus  https://t.co/NnrA8ohiGX
2. Equal Safety of JAK Inhibitors and TNF Inhibitors in H2H IMID trials JAMA systematic review.  https://t.co/HI1KBKZiXR
3. SMART study - Single vs. Split Dose Methotrexate  https://t.co/lizsrtVHwf
4. Vegan diets don’t work in RA - Metanalysis of 7 studies https://t.co/jeh6gN5Byg
5. No association between IL-17 inhibitors & MACEs (vs TNFi Rx)  https://t.co/fJuPFYKnSr https://t.co/Vscnsq0DTA
6. Successful Phase 3 UP-AA Trial evaluating Upadacitinib in Alopecia Areata (AA) https://t.co/8p1FvJx0s0
7. Anifrolumab effective & safe in refractory Cutaneous LE - OL Study in 15 CLE https://t.co/umEYz0XDyt
8. "Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has." - Margaret Mead https://t.co/OFGN223bPa

Big Fat FDA Pink Slip (9.19.2025)

Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com. Today we cover GLP-1 agonists, acupuncture, what JAKs wont do & an FDA Pink Slip.

Controversies in ILD

This deep dive into controversies in interstitial lung disease explored complex topics including IPAF, methotrexate, systemic autoimmune rheumatic disease vs. connective tissue disease distinctions, and the evolving role of anti-fibrotic therapy.

Panelists: Jeffrey Sparks, MD, Janet Pope, MD, Elena Joerns, MD
Jack Cush, MD - Moderator